AstraZeneca, Handa Settle SEROQUEL Patent Infringement Suit - Quick Facts

AstraZeneca Plc (AZN: News ,AZN.L: News ) said it has entered into a settlement agreement in its US SEROQUEL patent infringement litigation against Handa Pharmaceuticals, LLC regarding Handa's proposed generic version of AstraZeneca's SEROQUEL extended-release tablets. AstraZeneca stated that the agreement settles the patent infringement litigation filed by the company following Handa's submission to the US Food and Drug Administration...